Long-Term Liabilities: The sum of all non-current liabilities.
ZIVO Bioscience, Inc. (ZIVO) had Long-Term Liabilities of $0.34M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-4.21M |
|
-- |
|
-- |
|
$4.21M |
|
$-4.21M |
|
$-0.00M |
|
$-4.21M |
|
$-4.21M |
|
$-4.21M |
|
$-4.21M |
|
$-4.21M |
|
$-4.21M |
|
$-4.21M |
|
$-1.69M |
|
3.75M |
|
3.75M |
|
$-1.12 |
|
$-1.12 |
|
| Balance Sheet Financials | |
$1.02M |
|
-- |
|
$0.31M |
|
$1.33M |
|
$2.61M |
|
$0.08M |
|
|
Long-Term Liabilities |
$0.34M |
$2.95M |
|
$-1.62M |
|
$-1.62M |
|
$-1.62M |
|
3.79M |
|
| Cash Flow Statement Financials | |
$-1.43M |
|
-- |
|
$0.41M |
|
$1.54M |
|
$0.52M |
|
$-1.03M |
|
$0.60M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.39 |
|
-- |
|
-- |
|
-0.05 |
|
-0.14 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.43M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
260.39% |
|
260.39% |
|
-316.31% |
|
274.20% |
|
$-0.43 |
|
$-0.38 |
|
$-0.38 |
|